Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil in Heart Failure (SilHF)
NCT01616381Phase 3Unknown
- Sponsor
- Stavanger University Hospital
- Start
- Mar 2013
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial in heart failure (HF) and pulmonary hypertension (PH) comparing Sildenafil with Placebo (2 arms). Primary endpoints: Patient Global Assessment at 24 weeks and Six Minute Walk Test at 24 weeks. Status: unknown.
02
Drugs
sildenafil
03
Conditions
heart failure (HF)pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT01616381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01616381.